PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NC Research Campus

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

JC Med Launches with New Insulin Resistance Products - JC Med, a start-up biotech company, launched operations at the NC Research Campus (NCRC) in Kannapolis, NC, just outside of Charlotte, to produce insulin resistance supplements and to develop a first-of-its-kind, in-home insulin resistance meter
JC Med Launches with New Insulin Resistance Products

 

NewswireToday - /newswire/ - Kannapolis, NC, United States, 2013/12/18 - JC Med, a start-up biotech company, launched operations at the NC Research Campus (NCRC) in Kannapolis, NC, just outside of Charlotte, to produce insulin resistance supplements and to develop a first-of-its-kind, in-home insulin resistance meter.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Founder Wenhong Cao, MD, who is also a research associate professor in nutrition with the UNC Chapel Hill Nutrition Research Institute at the NCRC, has spent his career researching obesity and diabetes. With that knowledge, he has developed a dietary supplement to prevent insulin resistance that is initially being marketed in China through Shanghai Ideal Biotechnology, LLC. The profits from the supplements will fund the continued development of an in-home insulin resistance meter.

Insulin resistance or hyperglycemia is a condition where the body does not use the hormone insulin efficiently. As part of digestion, insulin is released from the pancreas to break down carbohydrates and fats in foods, and convert them to glucose. Insulin also assists cells in the absorption of glucose, which is an energy source. When the human body can no longer produce enough or absorb it efficiently, insulin resistance can result. For many, insulin resistance is a precursor to diabetes and a factor in the development of diseases like Alzheimer’s, fatty liver and other metabolic disorders.

“No one is treating insulin resistance,” Cao said. “Insulin resistance is evident up to 15 years before progressing to diabetes or any other disease. So there is a large window of time to make dietary changes, increase exercise or take supplements or some type of medication. By the time you have diabetes, the damage is done, and you can only manage it. There is no cure.”


About the NC Research Campus
The NC Research Campus is a 350-acre campus in Kannapolis, NC, just north of Charlotte, which is home to corporate, academic and healthcare partners focused on advancing science at the intersection of human health, agriculture and nutrition. Research and product development primarily focuses on breeding healthier fruits and vegetables, developing more effective functional food products and targeting new plant-based therapeutic and personalized approaches to the prevention and treatment of disease. The NCRC has a million square feet of lab and office space under management that includes five buildings and the research power of nine world-renowned universities and colleges in North Carolina. In addition to the university presence, the NCRC is home to General Mills, Sensory Spectrum, Monsanto, LabCorp, Dole Foods, Inc. and JC Med, LLC.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NC Research Campus

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


JC Med Launches with New Insulin Resistance Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Phyllis Beaver - NCResearchCampus.net 
704-250-5436 pbeaver[.]ncresearchcampus.net
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NC Research Campus securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NC Research Campus / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Explorers Vacation Club

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)